The Prescription Drug Affordability Board is finally moving on the task for which it was created back in 2019 – ensuring so called high-cost prescription drugs are affordable for Marylanders.
Semaglutide and tirzepatide are both glucagon-like peptide-1 receptor agonists or GLP-1 agonists. Although originally ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
Meaning, whether you lose weight through a change in your diet, a different medication, or bariatric surgery, there is a risk ...
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...
One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback